Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04247828 · ClinicalTrials.gov registry record · NA
Adaptive and Individualized AAC
A NA study, sponsored by Altec.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04247828 is a NA study that has completed, run by Altec. The registered enrollment target is 30 participants.
The verdict
NCT04247828, a NA study, has completed, sponsored by Altec.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This project will test the feasibility of developing a smart augmentative or alternative communication (AAC) system that is effective in delivering communication capabilities that automatically adapt to the users' physical abilities.
Interventions
- DEVICE Experimental AAC
- DEVICE Generic AAC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04247828
The ClinicalTrials.gov registry entry for NCT04247828 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Altec, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Experimental AAC is the first listed.
NCT04247828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04247828 about?
NCT04247828 is a clinical study titled "Adaptive and Individualized AAC". This project will test the feasibility of developing a smart augmentative or alternative communication (AAC) system that is effective in delivering communication capabilities that automatically adapt to the users' physical abilities.
What is the current status of trial NCT04247828?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-01-06. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT04247828?
The interventions under investigation include: Experimental AAC (DEVICE), Generic AAC (DEVICE).
Who is sponsoring clinical trial NCT04247828?
This trial is sponsored by Altec, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.